JUN and breast cancer: Furthermore, the antineoplastic efficacy of chemotherapy in MCF7 breast cancer cells was maintained when co-incubated with cytotoxic drugs and SP600125 (Supplementary Fig. S3), suggesting that c-Jun inhibition with SP600125 preferentially protects postmitotic neuronal cells but not cancer cells.